Javier Torres Corredor

Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer.

Richard Kelly, Andrew Jensen, Nathasha Karunaratna, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Phillip Parente, Arun A Azad, Anthony Uccellini, Javier Torres, Francis Parnis, Jeffrey Goh, Edmond M Kwan, Stephen Brown, Christopher Steer, Mark Warren, Peter Gibbs, Ben Tran, Angelyn Anton

Journal article  |  2023  |  BJU Int

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?

Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman

Journal article  |  2022  |  EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH

INTRODUCTION: Health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (ARTA) and docetaxe..

Telehealth in cancer care during the COVID-19 pandemic.

Kate Burbury, Peter Brooks, Leslie Gilham, Ilana Solo, Amanda Piper, Craig Underhill, Philip Campbell, Robert Blum, Stephen Brown, Frances Barnett, Javier Torres, Xiaofang Wang, William Poole, Anneke Grobler, Genevieve Johnston, Cassandra Beer, Hannah Cross, Zee Wan Wong

Journal article  |  2022  |  J Telemed Telecare

INTRODUCTION: The Victorian COVID-19 Cancer Network (VCCN) Telehealth Expert Working Group aimed to evaluate the telehealth (TH) e..

A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases.

Malinda Itchins, Hannah Ainsworth, Marliese Alexander, Samantha Dean, Devi Dharmaraj, Nick Pavlakis, Stephen J Clarke, Chris Brown, Javier Torres, Ayesha Saqib, Rahul Ladwa, Kenneth O'Byrne, Melissa Moore, Po Yee Yip, Ben Solomon, Tom John, Steven Kao, Paul Mitchell, Sagun Parakh

Journal article  |  2022  |  Clin Lung Cancer

BACKGROUND: There are limited real world data on the IMpower150 regimen in oncogene driven tumors and central nervous system metas..

165P Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer

R Kelly, SSL Wong, J Shapiro, AJ Weickhardt, P Parente, A Azad, A Uccellini, J Torres, F Parnis, E Kwan, S Brown, C Steer, M Warren, P Gibbs, A Anton, B Tran

Journal article  |  2022  |  Annals of Oncology

Uptake of bone-modifying agents in patients with HER2 metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.

Vanessa Wong, Richard de Boer, Catherine Dunn, Angelyn Anton, Laeeq Malik, Sally Greenberg, Belinda Yeo, Louise Nott, Ian M Collins, Javier Torres, Frances Barnett, Michelle Nottage, Peter Gibbs, Sheau Wen Lok

Journal article  |  2022  |  Intern Med J

BACKGROUND: International practice guidelines recommend administration of bone-modifying agents (BMA) in metastatic breast cancer ..

Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: An application of the TARGET-TP score.

Kate Burbury, Marliese Alexander, Samuel J Harris, Craig Underhill, Javier Torres, Sharad Sharma, Nora Lee, Hui-Li Wong, Richard Wilhelm Eek, Michael Michael, Jeanne Tie, Jennifer Rogers, Alexander Graham Heriot, David Ball, Michael Patrick MacManus, Rory Wolfe, Benjamin J Solomon

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

12116 Background: Interventional trials applying risk models for targeted-thromboprophylaxis (TP) for ambulatory cancer patients ..

Telehealth cancer care consultations during the COVID-19 pandemic: a qualitative study of the experiences of Australians affected by cancer

Victoria White, Alice Bastable, Ilana Solo, Seleena Sherwell, Sangeetha Thomas, Rob Blum, Javier Torres, Natalie Maxwell-Davis, Kathy Alexander, Amanda Piper

Journal article  |  2022  |  SUPPORTIVE CARE IN CANCER

BACKGROUND: In response to the onset of the COVID-19 pandemic, telehealth was rapidly rolled out in health services across Austral..

Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer.

Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran

Journal article  |  2022  |  BJUI Compass

INTRODUCTION: Several systemic therapies have demonstrated a survival advantage in metastatic castration resistant prostate cancer..

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Ciara Conduit, Blossom Mak, Wenjia Qu, Juliana Di Lulio, Ronan Burder, Matthias Bressel, Thomas Cusick, Haryana M Dhillon, Richard De Abreu Lourenco, Craig Underhill, Javier Torres, Megan Crumbaker, Florian Honeyball, Anthony Linton, Ray Allen, Ian D Davis, Susan J Clark, Lisa G Horvath, Kate L Mahon

Journal article  |  2022  |  THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

OBJECTIVE: To determine the efficacy and safety of intermittent docetaxel chemotherapy guided by circulating methylated glutathion..